Guangzhou Hongxinjing E-Commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Hongxinjing E-Commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LYSHIATSU. The owner is based in Guangzhou.

076, Building 7, 66 Scientist House,

No. 1190,Tianyuan Road,Tianhe District,

Guangzhou 510630 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LYSHIATSU
LYSHIATSU
Registered 2024

Trademark Classifications

Guangzhou Hongxinjing E-Commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangzhou Hongxinjing E-Commerce Co., Ltd. have?

Guangzhou Hongxinjing E-Commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Hongxinjing E-Commerce Co., Ltd. file in?

Guangzhou Hongxinjing E-Commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangzhou Hongxinjing E-Commerce Co., Ltd.'s most well-known trademarks?

Guangzhou Hongxinjing E-Commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as LYSHIATSU. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Hongxinjing E-Commerce Co., Ltd.'s trademark registration success rate?

Guangzhou Hongxinjing E-Commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.